Crossmark

The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis

Crossref DOI link: https://doi.org/10.1007/s40256-020-00407-z

Published Online: 2020-06-08

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hua, Yang

Sun, Jin-Yu

Su, Yue

Qu, Qiang

Wang, Hong-Ye

Sun, Wei

Kong, Xiang-Qing
License Information

Text and Data Mining valid from 2020-06-08

Version of Record valid from 2020-06-08
More Information

Article History

First Online: 8 June 2020

Compliance with Ethical Standards

:

: Yang Hua, Jin-Yu Sun, Yue Su, Qiang Qu, Hong-Ye Wang, Wei Sun, and Xiang-Qing Kong declare that they have no potential conflicts of interest that might be relevant to this work.

: No external funds were used in this work.

Document is current

Any future updates will be listed below